Cell and Molecular Biology of Breast Cancer
Highlighting recent advances in our understanding of breast cancer, this book is intended for a wide audience as a reference book. Included are reviews of genetics, epigenetics, various aspects of cell and molecular biology, and several other areas of breast cancer that are aimed at determining new...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Totowa, NJ :
Humana Press : Imprint: Humana Press,
2013.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- 1. Histopathology and grading of breast cancer
- 2. Multicentric/multifocal breast cancer: overview, biology and therapy
- 3. The immune system in breast cancer initiation and progression: role of epithelial to mesenchymal transition
- 4. Remodeling of the extracellular matrix: implications for cancer
- 5. Biology and treatment of basal-like breast cancer
- 6. Re-excision after lumpectomy for breast cancer
- 7. Novel anti-angiogenic therapies using naturally-occurring and synthetic drugs to combat progestin-dependent breast cancer
- 8. New insights on estrogen receptor actions in hormone-responsive breast cancer cells by interaction proteomics
- 9. Reprogramming breast cancer cells with embryonic microenvironments: insights from nodal signaling
- 10. Metastatic determinants: breast tumour cells in circulation
- 11. Breast cancer epigenetics: biomarkers and therapeutic potential
- 12. The impact of centrosome abnormalities on breast cancer development and progression with a focus on targeting centrosomes for breast cancer therapy
- 13. A New Perspective on Cyclin D1: beyond cell cycle regulation
- 14. Gene signatures of inflammatory breast cancer: epithelial plasticity and a cancer stem cell phenotype
- 15. An integrated human mammary epithelial cell culture system for studying carcinogenesis and aging
- 16. New breast cancer treatment considerations – a brief review of the use of genetically modified (attenuated) bacteria as therapy for advanced and metastatic breast cancer.
